Is specific IgE antibody analysis feasible for the diagnosis of methylenediphenyl diisocyanate-induced occupational asthma?

International Archives of Occupational and Environmental Health

Volumn 86, Issue 4, 2013, Pages 417-430

  Budnik, Lygia Therese ^a   Preisser, Alexandra M ^b   Permentier, Hjalmar ^c   Baur, Xaver ^d  

^a Department of Occupational Medicine   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c UNIVERSITY OF GRONINGEN   (Netherlands)

^d UNIVERSITY OF HAMBURG   (Germany)

Author keywords

(diphenylmethane 4; 40 diisocyanate); 440 methylenediphenyl diisocyanate; Albumin conjugates; Asthma diagnosis; Hypersensitivity pneumonitis; Immunological diagnosis; Isocyanate alveolitis; Isocyanates; MDI; Occupational asthma; Specific IgE antibodies; Specific IgG antibodies

Indexed keywords

SIGE;

4,4' DIPHENYLMETHANE DIISOCYANATE; 4,4'-DIPHENYLMETHANE DIISOCYANATE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; ISOCYANIC ACID DERIVATIVE; SERUM ALBUMIN;

ADULT; AGED; ARTICLE; BLOOD; CASE CONTROL STUDY; CHEMICALLY INDUCED DISORDER; CHEMISTRY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; IMMUNOLOGY; INHALATION TEST; MALE; MIDDLE AGED; OCCUPATIONAL ASTHMA; OCCUPATIONAL EXPOSURE; SKIN TEST; VITAL CAPACITY; ASTHMA, OCCUPATIONAL; CHEMICALLY INDUCED;

ADULT; AGED; ASTHMA, OCCUPATIONAL; BRONCHIAL PROVOCATION TESTS; CASE-CONTROL STUDIES; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; ISOCYANATES; MALE; MIDDLE AGED; OCCUPATIONAL EXPOSURE; SERUM ALBUMIN; SKIN TESTS; VITAL CAPACITY;

EID: 84886097771     PISSN: 03400131     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00420-012-0772-6     Document Type: Article

References (39)

1. Anees W, Blainey D, Moore VC, Robertson K, Burge PS (2011) Differentiating occupational asthmatics from non-occupational asthmatics and irritant-exposed workers. Occup Med (Lond) 61(3):190-195
2. AulDJ, BhaumikA,Kennedy AL, BrownWE, Lesage J,Malo JL (1999) Specific IgG response to monomeric and polymeric diphenylmethane diisocyanate conjugates in subjects with respiratory reactions to isocyanates. J Allergy Clin Immunol 103(5 Pt 1):749-755
3. Baur X (1983) Immunologic cross-reactivity between different albumin-bound isocyanates. J Allergy Clin Immunol 71(2):197- 205
4. Baur X (2007) Evidence for allergic reactions in isocyanate asthma. J Allergy Clin Immunol 119(3):757-758
5. Baur X, Richter G, Pethran A, Czuppon AB, Schwaiblmair M (1992) Increased prevalence of IgG-induced sensitization and hypersensitivity pneumonitis (humidifier lung) in nonsmokers exposed to aerosols of a contaminated air conditioner. Respiration 59(4):211- 214
6. Baur X, Marek W, Ammon J, Czuppon AB, Marczynski B, Raulf- Heimsoth M, Roemmelt H, Fruhmann G (1994) Respiratory and other hazards of isocyanates. Int ArchOccup Environ Health 66(3): 141-152
7. Baur X, Huber H, Degens PO, Allmers H, Ammon J (1998) Relation between occupational asthma case history, bronchial methacholine challenge, and specific challenge test in patients with suspected occupational asthma. Am J Ind Med 33(2):114-122
8. Baur X, Chen Z, Marczynski B (2001) Respiratory diseases caused by occupational exposure to 1,5-naphthalene-diisocyanate (NDI): results of workplace-related challenge tests and antibody analyses. Am J Ind Med 39(4):369-372
9. Bernstein DI, Korbee L, Stauder T, Bernstein JA, Scinto J, Herd ZL, Bernstein IL (1993) The low prevalence of occupational asthma and antibody-dependent sensitization to diphenylmethane diisocyanate in a plant engineered for minimal exposure to diisocyanates. J Allergy Clin Immunol 92(3):387-396
10. Bernstein DI, Cartier A, Cote J, Malo JL, Boulet LP, Wanner M, Milot J, L'Archeveque J, Trudeau C, Lummus Z (2002) Diisocyanate antigen-stimulated monocyte chemoattractant protein- 1 synthesis has greater test efficiency than specific antibodies for identification of diisocyanate asthma. Am J Respir Crit Care Med 166(4):445-450
11. Brandli O, Schindler C, Kunzli N, Keller R, Perruchoud AP (1996) Lung function in healthy never smoking adults: reference values and lower limits of normal of a Swiss population. Thorax 51(3):277-283
12. Brandli O, Schindler C, Leuenberger PH, Baur X, Degens P, Kunzli N, Keller R, Perruchoud AP (2000) Re-estimated equations for 5th percentiles of lung function variables. Thorax 55(2):173-174
13. Budnik LT, Nowak D, Merget R, Lemiere C, Baur X (2011) Elimination kinetics of diisocyanates after specific inhalative challenges in humans: mass spectrometry analysis, as a basis for biomonitoring strategies. J Occup Med Toxicol 6(1):9-18
14. Campo P, Wisnewski AV, Lummus Z, Cartier A, Malo JL, Boulet LP, Bernstein DI (2007) Diisocyanate conjugate and immunoassay characteristics influence detection of specific antibodies in HDIexposed workers. Clin Exp Allergy 37(7):1095-1102
15. Curwick CC, Bonauto DK, Adams DA (2006) Use of objective testing in the diagnosis of work-related asthma by physician specialty. Ann Allergy Asthma Immunol 97(4):546-550
16. Hendrick DJ (2002) Diagnostic tests for occupational asthma. Am J Respir Crit Care Med 166(4):436-437
17. Hur GY, Koh DH, Choi GS, Park HJ, Choi SJ, Ye YM, Kim KS, Park HS (2008) Clinical and immunologic findings of methylenediphenyl diisocyanate-induced occupational asthma in a car upholstery factory. Clin Exp Allergy 38(4):586-593
18. Jayet PY, Schindler C, Kunzli N, Zellweger JP, Brandli O, Perruchoud AP, Keller R, Schwartz J, Ackermann-Liebrich U, Leuenberger P (2005) Reference values for methacholine reactivity (SAPALDIA study). Respir Res 6:131
19. Jones MG, Floyd A, Nouri-Aria KT, JacobsonMR, Durham SR, Taylor AN, Cullinan P (2006) Is occupational asthma to diisocyanates a non-IgE-mediated disease? J Allergy Clin Immunol 117(3):663- 669
20. Kumar A, Dongari N, Sabbioni G (2009) New isocyanate-specific albumin adducts of 4,40-methylenediphenyl diisocyanate (MDI) in rats. Chem Res Toxicol 22(12):1975-1983
21. Lushniak BD, Reh CM, Bernstein DI, Gallagher JS (1998) Indirect assessment of 4,40-diphenylmethane diisocyanate (MDI) exposure by evaluation of specific humoral immune responses to MDI conjugated to human serum albumin. Am J Ind Med 33(5):471- 477
22. Maestrelli P, Boschetto P, Fabbri LM, Mapp CE (2009) Mechanisms of occupational asthma. J Allergy Clin Immunol 123(3):531-542
23. Malo JL, Chan-Yeung M (2009) Agents causing occupational asthma. J Allergy Clin Immunol 123(3):545-550
24. Mapp CE, Saetta M, Maestrelli P, Di Stefano A, Chitano P, Boschetto P, Ciaccia A, Fabbri LM (1994) Mechanisms and pathology of occupational asthma. Eur Respir J 7(3):544-554
25. Merget R, Marczynski B, Chen Z, Remberger K, Raulf-Heimsoth M, Willrot PO, Baur X (2002) Haemorrhagic hypersensitivity pneumonitis due to naphthylene-1,5-diisocyanate. Eur Respir J 19(2):377-380
26. Moore VC, Jaakkola MS, Burge CB, Pantin CF, Robertson AS, Burge PS (2010) Do long periods off work in peak expiratory flow monitoring improve the sensitivity of occupational asthma diagnosis? Occup Environ Med 67(8):562-567
27. Palikhe NS, Kim JH, Park HS (2011) Biomarkers predicting isocyanate-induced asthma. Allergy Asthma Immunol Res 3(1): 21-26
28. Sabbioni G, Dongari N, Kumar A (2010) Determination of a new biomarker in subjects exposed to 4,40-methylenediphenyl diisocyanate. Biomarkers 15(6):508-515
29. Sepai O, Henschler D, Sabbioni G (1995) Albumin adducts, hemoglobin adducts and urinary metabolites in workers exposed to 4,40-methylenediphenyl diisocyanate. Carcinogenesis 16(10): 2583-2587
30. Spiazzi A, Boccagni P, Germano P, Pezzini A (1991) RAST-detection of specific IgE in diphenylmethane diisocyanate exposed workers: considerations in performance of the test. Allergy 46(3): 166-172
31. Tarlo SM, Balmes J, Balkissoon R, Beach J, Beckett W, Bernstein D, Blanc PD, Brooks SM, Cowl CT, Daroowalla F, Harber P, Lemiere C, Liss GM, Pacheco KA, Redlich CA, Rowe B, Heitzer J (2008) Diagnosis and management of work-related asthma: American college of chest physicians consensus statement. Chest 134(3 Suppl):1S-41S
32. Tee RD, Cullinan P, Welch J, Burge PS, Newman-Taylor AJ (1998) Specific IgE to isocyanates: a useful diagnostic role in occupational asthma. J Allergy Clin Immunol 101(5):709-715
33. Vandenplas O, Malo JL, Dugas M, Cartier A, Desjardins A, Levesque J, Shaughnessy MA, Grammer LC (1993) Hypersensitivity pneumonitis-like reaction among workers exposed to diphenylmethane [correction to piphenylmethane] diisocyanate (MDI). Am Rev Respir Dis 147(2):338-346
34. Vandenplas O, Dressel H, Wilken D, Jamart J, Heederik D, Maestrelli P, Sigsgaard T, Henneberger P, Baur X (2011) Management of occupational asthma: cessation or reduction of exposure? A systematic review of available evidence. Eur Respir J 38(4):804-811
35. Wisnewski AV (2007) Developments in laboratory diagnostics for isocyanate asthma. Curr Opin Allergy Clin Immunol 7(2):138- 145
36. Wisnewski AV, Jones M (2010) Pro/Con debate: is occupational asthma induced by isocyanates an immunoglobulin E-mediated disease? Clin Exp Allergy 40(8):155-162
37. Wisnewski AV, Stowe MH, Cartier A, Liu Q, Liu J, Chen L, Redlich CA (2004) Isocyanate vapor-induced antigenicity of human albumin. J Allergy Clin Immunol 113(6):1178-1184
38. Wisnewski AV, Liu J, Redlich CA (2010) Antigenic changes in human albumin caused by reactivity with the occupational allergen diphenylmethane diisocyanate. Anal Biochem 400(2): 251-258
39. World-Health-Organization (2000) Diphenylene methane diisocyanate (MDI), international programme on chemical safety. Concise international chemical, Assessment Document 27. http://wwwinchemorg/documents/cicads/cicads/cicad27htm